Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cell Hypoxia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02128724
What this trial is testing

Palliative Thoracic Radiotherapy Plus BKM120

Who this might be right for
Carcinoma, Non-Small-Cell Lung
University of Oxford 21
Testing effectiveness (Phase 2)Ended earlyNCT05935748
What this trial is testing

Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)

Who this might be right for
ccRCCClear Cell Renal Cell CarcinomaKidney Cancer+18 more
NiKang Therapeutics, Inc. 18
Very early researchLooking for participantsNCT06747260
What this trial is testing

Feasibility and Safety of Intranasally Administered Breast Milk in HIE

Who this might be right for
Hypoxic Ischaemic Encephalopathy (HIE)Hypoxic Ischemic Encephalopathy of NewbornNeonatal Encephalopathy+4 more
Semmelweis University 10
Not applicableEnrolling By InvitationNCT07055503
What this trial is testing

Use of the Hemanext One® Hypoxic Red Blood Cell Storage System for Transfusion in Thalassemia Patients

Who this might be right for
Transfusion-dependent Beta-ThalassemiaBlood Transfusion
University Research Institute for the Study of Genetic & Malignant Disorders in Childhood 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06939270
What this trial is testing

CD73/AXL Targeted HypoSti.CAR-T Cells in CD73/AXL Positive Advanced/Metastatic Solid Tumors

Who this might be right for
Solid Tumor
Chinese PLA General Hospital 30
Not applicableEnded earlyNCT01881451
What this trial is testing

Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian Cancer

Who this might be right for
Ovarian CancerOvarian Neoplasms
British Columbia Cancer Agency 5
Not applicableUnknownNCT03806816
What this trial is testing

Use of Melatonin for Neuroprotection in Asphyxiated Newborns

Who this might be right for
Hypoxic-Ischemic EncephalopathyCell DamageAsphyxia Perinatal
University Hospital of Ferrara 100
Early research (Phase 1)Study completedNCT01649648
What this trial is testing

Autologous Cord Blood Cells for Brain Injury in Term Newborns

Who this might be right for
Hypoxic Ischemic Encephalopathy
National University Hospital, Singapore 2
Early research (Phase 1)Study completedNCT03635450
What this trial is testing

Study of hCT-MSC in Newborn Infants With Moderate or Severe HIE

Who this might be right for
Moderate to Severe Hypoxic-ischemic Encephalopathy
Joanne Kurtzberg, MD 6
Not applicableNot Yet RecruitingNCT07670455
What this trial is testing

Brain Radiotherapy Imaging for High-grade Glioma Using Hypoxia Targeting Through Oxygen-Enhanced Response

Who this might be right for
High Grade GliomasHypoxia BrainGlioblastoma (GBM)+1 more
The Leeds Teaching Hospitals NHS Trust 25
Not applicableStudy completedNCT07720960
What this trial is testing

Effects of Intermittent Hypoxia Training With Iron Supplementation on Red Blood Cells and Iron Levels in Trained Athletes

Who this might be right for
HypoxiaErythropoiesisIron Metabolism Disorders
Néstor Vicente-Salar 32
Not applicableUnknownNCT03319017
What this trial is testing

Apoptosis in Polymorphonuclear Cells and Inflammatory Cytokines of Trauma Patients

Who this might be right for
Trauma
Korea University Guro Hospital 100
Early research (Phase 1)Ended earlyNCT03573986
What this trial is testing

Pilot Study of 18F-FMISO PET/CT and MRI Imaging to Explore Tissue Hypoxia and Arteriovenous Shunting in Subjects With Recurrent Glioblastoma Before and After Bevacizumab Treatment

Who this might be right for
Recurrent Glioblastoma
Abramson Cancer Center at Penn Medicine 2
Testing effectiveness (Phase 2)Ended earlyNCT05119335
What this trial is testing

NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma

Who this might be right for
ccRCCClear Cell Renal Cell CarcinomaKidney Cancer+14 more
NiKang Therapeutics, Inc. 120
Very early researchLooking for participantsNCT06746532
What this trial is testing

Intranasal Breast Milk Therapy in HIE

Who this might be right for
Hypoxic-Ischaemic EncephalopathyNeonatal EncephalopathyPerinatal Asphyxia+1 more
Semmelweis University 80
Not applicableLooking for participantsNCT07527104
What this trial is testing

Autologous Bone Marrow Mononuclear Cell Transplantation Combined With Rehabilitation in Children With Sequelae of Hypoxic-Ischemic Encephalopathy or Intracranial Hemorrhage

Who this might be right for
Cerebral Palsy Hypoxic-Ischemic Encephalopathy Intracranial Hemorrhage
National Children's Hospital, Vietnam 60
Testing effectiveness (Phase 2)Ended earlyNCT01868906
What this trial is testing

FMISO-PET in Brain Tumors and SCS Effect

Who this might be right for
Malignant Glioma
Bernardino Clavo, MD, PhD 6
Testing effectiveness (Phase 2)Study completedNCT04063215
What this trial is testing

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy

Who this might be right for
Traumatic Brain Injury
Hope Biosciences LLC 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT06880289
What this trial is testing

Chemo-Radiotherapy Boost Treatment Guided by Perfusion MRI on Hypoxic Zones in Head and Neck Cancer

Who this might be right for
Squamous Cell Tumors of the Head and Neck
Regina Elena Cancer Institute 91
Large-scale testing (Phase 3)UnknownNCT02661152
What this trial is testing

DAHANCA 30: A Randomized Non-inferiority Trial of Hypoxia-profile Guided Hypoxic Modification of Radiotherapy of HNSCC.

Who this might be right for
Head and Neck Squamous Cell CarcinomaRadiotherapyHypoxic Modification+2 more
Danish Head and Neck Cancer Group 1,252
Next Page